109 related articles for article (PubMed ID: 11742478)
1. The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours.
Cook AM; Dzik-Jurasz AS; Padhani AR; Norman A; Huddart RA
Br J Cancer; 2001 Nov; 85(11):1624-6. PubMed ID: 11742478
[TBL] [Abstract][Full Text] [Related]
2. Avascular necrosis in patients treated with BEP chemotherapy for testicular tumours.
Coles C; Williams M
Clin Oncol (R Coll Radiol); 2000; 12(1):69. PubMed ID: 10749025
[No Abstract] [Full Text] [Related]
3. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
4. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
[TBL] [Abstract][Full Text] [Related]
5. Accelerated chemotherapy for poor prognosis germ cell tumours.
Horwich A; Dearnaley DP; Norman A; Nicolls J; Hendry WF
Eur J Cancer; 1994; 30A(11):1607-11. PubMed ID: 7530470
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
7. [Randomized phase III study on nonseminomatous testicular tumor].
Rexer H
Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
[No Abstract] [Full Text] [Related]
8. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
9. Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
Herlofson BB; Norman-Pedersen K; Redfors M; Fosså SD
Eur J Oral Sci; 1997 Oct; 105(5 Pt 2):523-6. PubMed ID: 9395118
[TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer.
Shoji S; Miyakita H; Shima M; Usui Y; Nagata Y; Uchida T; Terachi T
Hinyokika Kiyo; 2006 Sep; 52(9):723-6. PubMed ID: 17040060
[TBL] [Abstract][Full Text] [Related]
11. [Bleomycin-induced pneumonia].
Berger K; Göpfert A; Berkel H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
[TBL] [Abstract][Full Text] [Related]
12. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
13. [The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
Blanco Guerrero R; Germà Lluch JR; Climent Durán MA; Mercedes Ramírez A; Alonso Muñoz C; López Pousa A; López López JJ
Med Clin (Barc); 1991 Oct; 97(13):491-4. PubMed ID: 1721988
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
15. [BEP-chemotherapy in patients with testicular tumors--is it worthwhile?].
Hess U; Jungi WF; Morant R; Schmid L; Senn HJ; Bandhauer K
Schweiz Med Wochenschr; 1990 Dec; 120(49):1883-6. PubMed ID: 1702233
[TBL] [Abstract][Full Text] [Related]
16. Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
Cronin S; Uberti JP; Ayash LJ; Raith C; Ratanatharathorn V
Bone Marrow Transplant; 2000 Dec; 26(11):1247-9. PubMed ID: 11149742
[TBL] [Abstract][Full Text] [Related]
17. Acute anterior myocardial infarction after chemotherapy for testicular seminoma in a young patient.
Ozben B; Kurt R; Oflaz H; Sezer M; Basaran M; Goren T; Umman S
Clin Appl Thromb Hemost; 2007 Oct; 13(4):439-42. PubMed ID: 17911198
[TBL] [Abstract][Full Text] [Related]
18. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Bamias A; Aravantinos G; Kastriotis I; Alivizatos G; Anastasiou I; Christodoulou C; Gyftaki R; Kalofonos HP; Dimopoulos MA
Urol Oncol; 2011; 29(2):189-93. PubMed ID: 19362863
[TBL] [Abstract][Full Text] [Related]
19. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
[TBL] [Abstract][Full Text] [Related]
20. Avascular necrosis of bone caused by combination chemotherapy without corticosteroids.
Harper PG; Trask C; Souhami RL
Br Med J (Clin Res Ed); 1984 Jan; 288(6413):267-8. PubMed ID: 6198019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]